Experience
Three CEO tenures, and the operating career that led to them.
Chief executive of one NYSE-listed company and two private-equity-owned companies, after senior operating roles at Albemarle and FMC. BS in Chemistry and MBA, University of North Carolina at Chapel Hill.
2022 to 2025
Vibrantz Technologies
President and CEO. Formed and integrated a $2 billion company from Prince International, Chromaflo Technologies and Ferro Corporation.
- More than $150 million in cost synergies and productivity gains within 24 months of formation
- Recordable injuries down more than 60%
- Inventory cut by more than 20%; first EcoVadis rating and first sustainability report
2020 to 2022
Prince International
President and CEO. Led the $2.1 billion acquisition of Ferro Corporation.
- Took the helm in November 2020, mid-pandemic; grew 2021 revenue 14% and adjusted EBITDA 16%
- Doubled the new-product vitality index from 8% to 16% of revenue
- Improved recordable injury rate by 41%
2015 to 2020
Ingevity (NYSE: NGVT)
President, CEO and Director. Led the spin-off from WestRock and doubled EBITDA from $200 million to $400 million.
- Named Forbes' #1 spin-off of 2016; market value more than quadrupled to $4.5 billion
- Grew revenue from about $900 million to $1.3 billion and deployed about $1 billion across three acquisitions
- Top-quartile American Chemistry Council safety performance; first sustainability report
2013 to 2015
Albemarle (NYSE: ALB)
Executive Vice President and President, Performance Chemicals, a $1.6 billion unit spanning lithium and bromine; earlier President, Catalyst Solutions. Co-led the $6.2 billion acquisition of Rockwood Holdings and its integration.
- Revenue growth of 9%, two to three times the industry rate, and segment income up 15%
- Working capital down $88 million, or 29 days
- Lost-time injury rate cut from 0.63 to 0.23, top quartile
1997 to 2013
FMC Corporation (NYSE: FMC)
Led FMC Lithium, the Industrial Chemicals Group and the $1 billion Specialty Chemicals Group, as a member of the Corporate Executive Committee.
- Turned around FMC Lithium: $24 million earnings improvement across six plants on four continents
- Industrial Chemicals: $550 million revenue growth and $170 million earnings improvement over five years
- Record BioPolymer earnings in 2011 and 2012; launched FMC's corporate sustainability program
1984 to 1997
Rexam and Wausau Paper
Began as a product development chemist; ran businesses as general manager of Laminex and of Wausau's Technical Specialty division.
- Wausau: 12% volume and 35% operating profit growth in a down market; acquired the third-largest U.S. competitor
- Laminex: returned the company to profitability and led its sale
On the ground




